logo
Select company
Select metric
Ticker Information

Ticker

CURX

Company Name

CURANEX PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CURANEX PHARMACEUTICALS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CURX - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ 0$ 0124M
3/31/2025$ 0$ 0124M
12/31/2024$ -361.51K$ -0.03113.26M
9/30/2024$ 0$ 0124M
12/31/2023$ -17.38K$ -0.0211M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CURANEX PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -0.02.
  • Over the past 5 years, CURANEX PHARMACEUTICALS INC's average EBITDAPS has been $ -0.02.
  • The median EBITDAPS for CURANEX PHARMACEUTICALS INC during this period was $ -0.02
  • CURANEX PHARMACEUTICALS INC reached its highest EBITDAPS over the past 5 years at $ -0.02.
  • The lowest EBITDAPS recorded by CURANEX PHARMACEUTICALS INC in the same timeframe $ -0.03

CURANEX PHARMACEUTICALS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
CRDF : CARDIFF ONCOLOGY INC $ -0.76MNPR : MONOPAR THERAPEUTICS $ -2.47TVRD : TVARDI THERAPEUTICS INC $ -1.63CRGX : CARGO THERAPEUTICS INC $ -4.5DSGN : DESIGN THERAPEUTICS INC $ -1.11TRDA : ENTRADA THERAPEUTICS INC $ -1.77VOR : VOR BIOPHARMA INC $ -263.72LCTX : LINEAGE CELL THERAPEUTICS INC $ -0.18ALLO : ALLOGENE THERAPEUTICS INC $ -1.02EDIT : EDITAS MEDICINE INC $ -2.79

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for CURANEX PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -17.38K ] / (Shares WA [ 1M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -0.02 ]

CURX - EBITDA per Share, Last 5 years

$ -0.03

Minimum

Dec 31, 2024

$ -0.02

Maximum

Dec 31, 2023

$ -0.02

Average

$ -0.02

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26